We describe a simple, rapid, automated procedure for measuring opsonophagocytosis and killing of Candida albicans by human peripheral blood leukocytes. of opsonophagocytosis, which was essentially complete after 20 min at 37°C, and killing rates, which were 48% 11% and 63% 9% (standard deviation) after 1 and 2 h, respectively, when yeast cell-to-phagocyte ratios were in the range of 0.5:1 to 2:1. The described assay is unrivaled in simplicity, rapidity, and reproducibility and generates results for a large number of samples within hours.
Phagocytic killing is the primary mechanism through which the immune system eliminates gram-positive and serum-resistant gram-negative organisms and pathogenic fungi. Deficiencies in phagocyte function, whether primary or secondary, therefore can result in life-threatening infections with microorganisms that otherwise display relatively low virulence or invasive tendency. The mechanisms underlying opsonophagocytosis are known in great detail, and specialized laboratories can today analyze and identify the causes of phagocytic malfunction at a molecular level. These impressive advances are in contrast to, on the other hand, a basic dilemma relating to the nonavailability of a rapid, simple, and reproducible method for simultaneously measuring opsonophagocytosis at the individual cell level and the extent of killing of the target microorganism in a completely autologous system. Colony counting, the "gold standard" for assaying killing, is slow and cumbersome and requires considerable expertise to be reproducible (42) . Opsonophagocytosis can be quantified by assessing the numbers of radiolabelled microorganisms that become cell associated or by measurements of uptake of radiolabelled nucleotides by the target organisms (3, 15, 20, 33, 39, 45, 47) . However, the necessity of handling radioisotopes mitigates against wide usage of such methods, and, in addition, quantification of killing in these systems is neither easy nor straightforward. Fluorescein-labelled bacteria have been used as targets; in these cases, adherent or ingested cells can be enumerated microscopically or by measuring total cell-associated fluorescence (27, 30, 31, 41) . These assays are elegant but do not * Corresponding author. assess killing, and they are still not simple enough to become routine tests. Differential staining with acridine orange has been described as a means to quantify phagocytic killing (12, 37, 38, 46) . However, this approach harbors some danger of artifacts (5) , and results cannot be validated by parallel determinations of numbers of CFU.
Today, the technique originally developed by or modifications thereof (14, 36, 38) still represent the most widely used assays for measuring phagocytic killing of Candida albicans. The basis for these methods is that phagocytes can be solubilized by deoxycholate (DOC) to liberate ingested yeast cells, which then stain differentially with conventional dyes (e.g., methylene blue), depending on whether they are viable or killed. This technique is conceptually elegant but necessitates counting in the microscope.
Ideally, a phagocytosis test should meet the following demands. First, it should be easy to perform, requiring no special skills or handling of hazardous material (isotopes). Second, it should provide quantitative data both on the opsonophagocytic function at the individual-cell level and on the extent of killing of the target cells. Third, data acquisition should be rapid and automated. In this communication, we describe a novel phagocytosis assay that fulfills these criteria by using C. albicans cells as targets. The test is conceptually related to the original assay of Lehrer (22, 25) (28) . These processes were deleterious for the assay because they led to erratic reductions in numbers of CFU in the controls. The processes were found to be fully inhibitable by the addition of 0. Figure 1 depicts the results of fluorescence-activated analysis of labelled C. albicans (A and B), My-7-labelled CRP (C and D), and labelled CRP spiked with labelled yeast cells at time zero (E and F). The labelled yeast cells were satisfactorily homogeneous with respect to size and fluorescence intensity. In the fluorescence microscope, the cells were observed to present bright cytoplasmic fluorescence that was confined to a relatively small portion of the intracellular compartment. The nonfluorescent areas were presumably occupied by the cell nucleus and organelles. Over 90% of the yeast cells were fluorescent at the commencement of the experiments. After incubation with MAb My 7,  peripheral blood cells presented a normal pattern with regard to size distribution and granularity (Fig. 1C) (Fig. 1F) . Fluorescent yeast cells bound to or phagocytosed by leukocytes caused a shift of the latter from monochromatic (orange) to dual (orange-green) fluorescence. No attempts were undertaken in this study to differentiate extracellular, adherent organisms from ingested particles. Figures 2 and 3 depict the results of experiments conducted at yeast cell-to-granulocyte ratios of 1:1, evaluated by fluorescence-activated cell analysis. As expected, the shift towards green fluorescence occurred exclusively in the phagocyte cell population. The shift became initially detectable after 5 min of incubation at 37°C, was maximal after 20 min, and remained essentially constant over the following 40 min. Concomitantly, there was a decrease in the number of green yeast particles to virtually nil when PMN-to-yeast cell ratios were 1:1. If required, the relative percentage of yeast cells becoming associated with blood cells could be quantified by observing the reduction of particles in a respective window.
When the yeast cell-to-phagocyte ratio was increased to 3:1, the kinetics of opsonophagocytosis remained essentially the same, but a higher percentage of phagocytes finally bound yeast particles. A small number of nonphagocytosed yeast cells remained detectable, despite the fact that a small percentage of phagocytes was not loaded (Fig. 3) . The participation of phagocytes in opsonophagocytosis could be studied at the single-cell level by live-gating the orange, fluorescent particles. In the experiment, 17, 57, and 63% of the phagocytes exhibited a green shift within 5, 10, and 20 min, respectively (Fig. 4) . The gating in this experiment was selected to include mainly granulocytes. Specific inclusion or analysis of monocytes is, of course, also feasible.
Of note, at the yeast cell-to-PMN ratio of 1:1, 63% of the PMNs became associated with yeast particles, indicating that yeast cell-phagocyte association occurred randomly. When the yeast load was increased to 3:1, 36, 83, and 85% of the phagocytes exhibited a green shift after 5, 10, and 20 min, respectively (calculated from data of Fig. 3 ). No association of yeast particles with phagocytes was observed in samples that had been incubated on ice for 60 min (Fig. 2 to 4) .
The association with and uptake of yeast cells by phagocytes were readily observable by microscopy. Because the BCECF fluorescence faded rapidly, photographic documentation was not possible, and, as a result, we are limited to written descriptions. At the commencement of the assays, free yeast particles (green), phagocytes (orange), and nonfluorescent cells could be distinguished. After 15 to 20 min at 37°C, no free yeast cells could be detected and most appeared to be located within the phagocytes. In (Fig. SA) . In contrast, when samples containing CRP and yeast cells were treated with DOC, there was a progressive decrease in the number of fluorescent particles and a concomitant increase of nonfluorescent cells over time (Fig. SA) . The suspicion that this reflected phagocytic killing, with nonfluorescent particles representing nonviable yeast cells that had been liberated from the detergent-solubilized granulocytes, was confirmed by colony counting. A total of 33 determinations conducted after 1 and 2 h of incubation were performed by using blood from seven healthy individuals. To calculate killing by fluorescence analysis, labelled versus unlabelled particles were enumerated in the CRP samples and compared with the respective controls (yeast cells in CFP). An example is shown in Fig. 5B , wherein 87 and 82% of the yeast cells were fluorescent in the CFP control sample after 60 and 120 min, respectively, compared with 49 and 32% fluorescent particles in the CRP sample. Killing was thus estimated to be (87 -49)/87 = 44% and (82 -32)/82 = 60% after 1 and 2 h, respectively. The killing estimates derived by fluorescenceactivated cell sorter analysis never deviated by more than 20% from determinations obtained by colony countings. The flow cytometric determinations indicated that 48% + 11% and 62% + 10% (standard deviation) killing occurred after 60 and 120 min, respectively, at 37°C. The data obtained by colony counting were 54% +± 14% and 76% + 10%, respectively. Three experiments were conducted in which killing was additionally quantified after 15, 30, and 45 min, and the collective results of all flow cytometric assays are depicted in Fig. 6 .
To determine whether killing was dependent on the presence of amphotericin B at the given concentration of 0.5 ,ug/ml, additional experiments (n = 3) were conducted over 60 min in the presence of the fungicidal agent. Killing rates were identical in both cases. Thus, we detected no synergism between amphotericin B and phagocytic killing under the given experimental conditions. The same results were recently reported by Nugent and Couchot (29) . (18) and Bjerknes and Bassoe (6) described flow cytometric analysis of the ingestion of heat-killed yeast particles. These assays also do not measure killing. Most recently, a method has been devised to quantify protein degradation in phagolysosomes by flow cytometry (17) .
One attractive method for measuring phagocytosis and killing of C. albicans by using flow cytometry was described by Bjerknes (5) . The assay was conducted with isolated PMNs and exploited differential staining of dead and viable yeast cells with propidium iodide after their liberation from phagocytes by lysis in water. Buschmann and Winter (9) extended the method to assay killing of baker's yeast. Derer et al. (12) (22, 25, 26) . Their data, therefore, indicated a marked temporal dissociation between the process of ingestion and killing. Notably, diverging results were reported by other investigators who utilized differential staining with acridine orange (38) The relatively slow killing rate of ingested C. albicans markedly contrasts with the rapid bactericidal activity of peripheral blood leukocytes. Killing of staphylococci and streptococci is essentially complete (over 90%) within 30 min, and smooth strains of the family Enterobacteriaceae are also killed within 60 min (42, 44, 45) . In contrast, we never observed more than 75% killing of C. albicans even after 120 min. A possible explanation for incomplete killing of C. albicans based on phagocyte vacuole heterogeneity has been suggested by Cech and Lehrer (11) . Slow killing of C. albicans by neutrophils could indicate that blood phagocytes may not efficiently effect their elimination during systemic infections. Possibly, activated macrophages represent another important arm of defense against these organisms (7, 37, 43) . Many investigators have used other Candida species (e.g., C. guilliermondii, C. pseudotropicalis, C. parapsilosis) as targets in phagocytosis assays (14, 24, 35, 37, 43) , because these fungi either exert little cytocidal effect on phagocytes, do not form pseudohyphae, or may be killed via other mechanisms not involving the myeloperoxidase pathway. We elected to use C. albicans because of its prominent medical significance, whereby pseudohypha formation and aggregation were suppressed by addition of amphotericin B at a subfungicidal concentration. These effects of amphotericin B have also been demonstrated by Nugent and Couchot (29) .
The use of MAb My-7 to label blood phagocytes rendered the study of opsonophagocytosis possible at the single-cell level. This antibody did not affect opsonophagocytic function. However, an effect on killing of C. albicans was noted and is currently being investigated.
We did not attempt to differentiate between adherent and ingested yeast cells. If necessary, this might be possible through the use of an appropriate quenching agent (18) or by using a triple label (e.g., specific antibody [32, 41] ) to probe the location of the yeast cells. Even when yeast cells were present in surplus, we constantly observed a small population of phagocytes displaying no dual fluorescence. This could reflect the existence of subpopulations of phagocytes with differing opsonophagocytic activities. The possibility that the cells became nonfunctional during the course of the expenments cannot be excluded, although our experimental protocol minimizes manipulation of blood samples to the extreme. It is reiterated that the only processing step that our assay requires is a 20-to 30-min dextran sedimentation of erythrocytes, so that artifactual alterations of leukocyte function are not expected. We have ascertained that the granulocytes present in the CRP do not show enhanced production of superoxide anions. They neither aggregate nor secrete elastase, and they phagocytose S. aureus (10 bacteria per granulocyte) within 60 min (data not shown). Finally, since dextran selectively causes erythrocyte sedimentation, the composition and content of other cells in CRP preparations most closely resemble the in vivo situation.
The procedure described in the present study is very simple and generates results within a few hours. A large number of samples can be processed, and this will facilitate investigations into various aspects of phagocytosis. Obvious possibilities include studies on the opsonic requirement for phagocytosis, the identification of cell surface molecules that participate in uptake of microorganisms, the involvement of intracellular machineries in the killing process, the production of antiphagocytic substances by microorganisms, and the possible augmentation of microbicidal phagocyte function by cytokines. In a clinical laboratory setting, our method provides a novel means to screen for primary and secondary defects in phagocyte function, irrespective of whether the cause lies in the humoral or cellular arm of the immune system.
